SSTP1

General Information


DRACP ID  DRACP01074

Peptide Name   SSTP1

Sequence  FLPLLISALTSLFPKLGK

Sequence Length  18

UniProt ID  Not available

PubChem CID  Not available

Origin  Skin Secretion of Indosylvirana aurantiaca

Type  Native peptide

Classification

  

Active ACP Cancer targeted peptides



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HSC-4 Tongue squamous cell carcinoma; Squamous cell carcinoma of the oral tongue Carcinoma IC50=10.22 μM MTT assay 48h 1
MDA-MB-231 Breast adenocarcinoma Carcinoma IC50=4.5 μM MTT assay 48h 1

Hemolytic Activity  Human red blood cell: SSTP1-induced hemolysis at 5 μM was only-0.25%

Normal (non-cancerous) Cytotoxicity  HEK293: IC50=21.72 μM, lower cytotoxicity

Target  IL6/IL6Rα/gp130 complex

Affinity  Not available

Mechanism  In IL6Rα-overexpressing cancer cells, SSTP1 induces apoptosis at low concentration through JNK pathway, without causing significant membrane disruption.

Nature  Anticancer; Antitumor



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01074

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C97H160N20O22

Absent amino acids  CDEHMNQRVWY

Common amino acids  L

Mass  226187

Pl  10.81

Basic residues  2

Acidic residues  0

Hydrophobic residues  10

Net charge  2

Boman Index  2268

Hydrophobicity  116.67

Aliphatic Index  157.22

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 34867962

Title  SSTP1, a Host Defense Peptide, Exploits the Immunomodulatory IL6 Pathway to Induce Apoptosis in Cancer Cells

Doi 10.3389/fimmu.2021.740620

Year  2021

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.